Brief: Agile Therapeutics Received Notice To Regain Compliance With Nasdaq Listing Rule
05/06/2023 16:23
June 5 (Reuters) - Agile Therapeutics Inc AGRX.O :
* AGILE THERAPEUTICS: ON JUNE 2, GOT LETTER FROM NASDAQ
NOTIFYING
CO HAD BEEN GRANTED UNTIL SEPT 25, TO REGAIN COMPLIANCE WITH
NASDAQ LISTING RULE
Source text for Eikon: ID:
Further company coverage: AGRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Agile Therapeutics
See all newsBrief: Agile Therapeutics Inc. Announces Definitive Merger Agreement With Insud Pharma, S.L.
Agile Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Agile Therapeutics Announces Delisting From Nasdaq
Agile Therapeutics Inc expected to post a loss of 54 cents a share - Earnings Preview
Brief: Agile Therapeutics Completes Pay-Off Of Debt